Donofrio LM - Search Results

1

A randomized, placebo-controlled, double-blind phase III trial investigating the efficacy and safety of incobotulinumtoxinA in the treatment of glabellar frown lines using a stringent composite endpoint.

Hanke CW, Narins RS, Brandt F, Cohen JL, Donofrio LM, Downie J, Heinz M, Harrington L, McDaniel DH, Nestor M, Schlessinger J, Schlöbe A, Taub A, Weiss RA. Hanke CW, et al. Among authors: donofrio lm. Dermatol Surg. 2013 Jun;39(6):891-9. doi: 10.1111/dsu.12160. Epub 2013 Mar 18. Dermatol Surg. 2013. PMID: 23506308 Clinical Trial.

2

Multicenter, randomized, phase III study of a single dose of incobotulinumtoxinA, free from complexing proteins, in the treatment of glabellar frown lines.

Carruthers A, Carruthers J, Coleman WP 3rd, Donofrio L, Flynn T, Gold M, Heinz M, Harrington L, Jones D, McDaniel D, Rohrer T, Schlöbe A, Solish N, Weiss RA. Carruthers A, et al. Dermatol Surg. 2013 Apr;39(4):551-8. doi: 10.1111/dsu.12100. Epub 2013 Feb 4. Dermatol Surg. 2013. PMID: 23379292 Clinical Trial.

3

Comparison of Hyaluronic Acid Gel With (HARDL) and Without Lidocaine (HAJUP) in the Treatment of Moderate-To-Severe Nasolabial Folds: A Randomized, Evaluator-Blinded Study.

Baumann L, Weiss RA, Grekin S, Narins R, Gold M, Donofrio L, Nogueira A, Shawcross H, Brown S, Mashburn JH. Baumann L, et al. Dermatol Surg. 2018 Jun;44(6):833-840. doi: 10.1097/DSS.0000000000001424. Dermatol Surg. 2018. PMID: 29799827 Clinical Trial.

4

An analysis of efficacy data from four phase III studies of botulinum neurotoxin type A-ABO for the treatment of glabellar lines.

Baumann L, Brandt FS, Kane MA, Donofrio LM. Baumann L, et al. Among authors: donofrio lm. Aesthet Surg J. 2009 Nov;29(6 Suppl):S57-65. doi: 10.1016/j.asj.2009.09.012. Aesthet Surg J. 2009. PMID: 19945006

5

Randomized sham-controlled trial to evaluate the safety and effectiveness of a high-intensity focused ultrasound device for noninvasive body sculpting.

Jewell ML, Baxter RA, Cox SE, Donofrio LM, Dover JS, Glogau RG, Kane MA, Weiss RA, Martin P, Schlessinger J. Jewell ML, et al. Among authors: donofrio lm. Plast Reconstr Surg. 2011 Jul;128(1):253-262. doi: 10.1097/PRS.0b013e3182174278. Plast Reconstr Surg. 2011. PMID: 21701341 Clinical Trial.

6

Improvement in nasolabial folds with a hyaluronic acid filler using a cohesive polydensified matrix technology: results from an 18-month open-label extension trial.

Narins RS, Coleman WP 3rd, Donofrio LM, Jones DH, Maas C, Monheit G, Kaur M, Grundy SL, Pappert EJ, Hardas B. Narins RS, et al. Among authors: donofrio lm. Dermatol Surg. 2010 Nov;36 Suppl 3:1800-8. doi: 10.1111/j.1524-4725.2010.01735.x. Dermatol Surg. 2010. PMID: 20969657 Clinical Trial.

7

A randomized, evaluator-blinded, controlled study of the effectiveness and safety of small gel particle hyaluronic acid for lip augmentation.

Glogau RG, Bank D, Brandt F, Cox SE, Donofrio L, Dover J, Grekin S, Lawrence I, Lin X, Nestor M, Shamban A, Stewart D, Weiss R, Axford-Gatley RA, Theisen MJ, Smith S. Glogau RG, et al. Dermatol Surg. 2012 Jul;38(7 Pt 2):1180-92. doi: 10.1111/j.1524-4725.2012.02473.x. Dermatol Surg. 2012. PMID: 22759255 Clinical Trial.

8

Unique injection techniques, including volumizing the forehead, advance the ways we rejuvenate the face. Introduction.

Narins RS, Donofrio LM. Narins RS, et al. Among authors: donofrio lm. Dermatol Surg. 2010 Nov;36 Suppl 3:1799. doi: 10.1111/j.1524-4725.2010.01792.x. Dermatol Surg. 2010. PMID: 20969656 No abstract available.

9

Safety and tolerability of high-intensity focused ultrasonography for noninvasive body sculpting: 24-week data from a randomized, sham-controlled study.

Jewell ML, Weiss RA, Baxter RA, Cox SE, Dover JS, Donofrio LM, Glogau RG, Kane MC, Martin P, Lawrence ID, Schlessinger J. Jewell ML, et al. Among authors: donofrio lm. Aesthet Surg J. 2012 Sep;32(7):868-76. doi: 10.1177/1090820X12455190. Aesthet Surg J. 2012. PMID: 22942114 Clinical Trial.

10

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Repeated OnabotulinumtoxinA Treatments in Subjects With Crow's Feet Lines and Glabellar Lines.

Carruthers J, Rivkin A, Donofrio L, Bertucci V, Somogyi C, Lei X, Davis PG, Campo A, Beddingfield FC. Carruthers J, et al. Dermatol Surg. 2015 Jun;41(6):702-11. doi: 10.1097/DSS.0000000000000357. Dermatol Surg. 2015. PMID: 25993609 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

41 results

Search Page

Filters